Adverse events survey
Raising the standards of pharma social compliance
How today's pharma compliance leaders view the rise of social media and its risk to adverse event detection.
Key findings
- Social media activity in pharma is expected to rise
- Pharma brands employ a variety of social compliance solutions
- Adverse events are slipping through the cracks
- AE detection is being regulated to junior-level team members
- Inconsistencies and irregularities plague social compliance efforts
About Crisp
Crisp partners with pharmacovigilance and drug safety teams to keep their social media presence safe and compliant, detecting potential adverse events on brand-sponsored social media pages, advertisements, and social listening platforms.
By combining human intelligence with expert workflows, we deliver drug-specific, continually-tuned, 24/7 compliance with zero misses on potential adverse events, assuring peace of mind for pharmacovigilance leaders, and giving marketers and their agency partners the confidence to engage consumers online.